英科医疗子公司拟7000万美元参投Warburg Pincus Global Growth 15,L.P

Core Viewpoint - Yingke Medical (300677.SZ) plans to invest in Warburg Pincus Global Growth 15, L.P. through its wholly-owned subsidiary, Yingke Medical International (Hong Kong) Limited, committing $70 million as a limited partner in a fund targeting a total raise of $17 billion [1] Group 1 - Yingke Medical International will participate in the investment using its own funds [1] - The partnership aims to invest in sectors including healthcare, energy transition, business services, industrial, technology, consumer, and sustainable development [1] - The fund will focus on growth capital transactions, early-stage growth platforms, acquisitions, capital restructuring, and other special situations [1]